2018 FDA tides harvest
File(s)
Published version
OA Location
Author(s)
Al Shaer, Danah
Al Musaimi, Othman
Albericio, Fernando
de la Torre, Beatriz G
Type
Journal Article
Abstract
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
Date Issued
2019-04-05
Date Acceptance
2019-04-03
Citation
Pharmaceuticals, 2019, 12 (2), pp.1-6
ISSN
1424-8247
Publisher
MDPI AG
Start Page
1
End Page
6
Journal / Book Title
Pharmaceuticals
Volume
12
Issue
2
Copyright Statement
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000477028700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Pharmacology & Pharmacy
dotatate
drugs
inotersen
Lutathera
oligonucleotides
Onpattro
patisiran
peptides
pharmaceutical market
Tegsedi
Publication Status
Published
Article Number
ARTN 52
Date Publish Online
2019-04-05